Literature DB >> 24449809

Invasive assessment of pulmonary hypertension: time for a more fluid approach?

Barry A Borlaug1.   

Abstract

Entities:  

Keywords:  Editorials; heart failure; heart failure with preserved ejection fraction; hemodynamics; pulmonary hypertension

Mesh:

Year:  2014        PMID: 24449809     DOI: 10.1161/CIRCHEARTFAILURE.113.000983

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


× No keyword cloud information.
  11 in total

Review 1.  Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies.

Authors:  Kavita Sharma; David A Kass
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

2.  Haemodynamics of Heart Failure With Preserved Ejection Fraction: A Clinical Perspective.

Authors:  Mauro Gori; Attilio Iacovoni; Michele Senni
Journal:  Card Fail Rev       Date:  2016-11

3.  Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report.

Authors:  John H Newman; Stuart Rich; Steven H Abman; John H Alexander; John Barnard; Gerald J Beck; Raymond L Benza; Todd M Bull; Stephen Y Chan; Hyung J Chun; Declan Doogan; Jocelyn Dupuis; Serpil C Erzurum; Robert P Frantz; Mark Geraci; Hunter Gillies; Mark Gladwin; Michael P Gray; Anna R Hemnes; Roy S Herbst; Adrian F Hernandez; Nicholas S Hill; Evelyn M Horn; Kendall Hunter; Zhi-Cheng Jing; Roger Johns; Sanjay Kaul; Steven M Kawut; Tim Lahm; Jane A Leopold; Greg D Lewis; Stephen C Mathai; Vallerie V McLaughlin; Evangelos D Michelakis; Steven D Nathan; William Nichols; Grier Page; Marlene Rabinovitch; Jonathan Rich; Franz Rischard; Sharon Rounds; Sanjiv J Shah; Victor F Tapson; Naomi Lowy; Norman Stockbridge; Gail Weinmann; Lei Xiao
Journal:  Am J Respir Crit Care Med       Date:  2017-06-15       Impact factor: 21.405

Review 4.  Pulmonary Vascular Disease: Hemodynamic Assessment and Treatment Selection-Focus on Group II Pulmonary Hypertension.

Authors:  Bhavadharini Ramu; Brian A Houston; Ryan J Tedford
Journal:  Curr Heart Fail Rep       Date:  2018-04

Review 5.  Pulmonary vascular disease in the setting of heart failure with preserved ejection fraction.

Authors:  Andrea R Levine; Marc A Simon; Mark T Gladwin
Journal:  Trends Cardiovasc Med       Date:  2018-08-17       Impact factor: 6.677

6.  Clinical and hemodynamic factors in predicting response to fluid challenge during right heart catheterization.

Authors:  Nima Moghaddam; John R Swiston; Robert D Levy; Lisa Lee; Victor F Huckell; Nathan W Brunner
Journal:  Pulm Circ       Date:  2018-12-03       Impact factor: 3.017

7.  Pulmonary hypertension due to left heart disease.

Authors:  Jean-Luc Vachiéry; Ryan J Tedford; Stephan Rosenkranz; Massimiliano Palazzini; Irene Lang; Marco Guazzi; Gerry Coghlan; Irina Chazova; Teresa De Marco
Journal:  Eur Respir J       Date:  2019-01-24       Impact factor: 16.671

8.  Pathophysiology of the right ventricle and of the pulmonary circulation in pulmonary hypertension: an update.

Authors:  Anton Vonk Noordegraaf; Kelly Marie Chin; François Haddad; Paul M Hassoun; Anna R Hemnes; Susan Roberta Hopkins; Steven Mark Kawut; David Langleben; Joost Lumens; Robert Naeije
Journal:  Eur Respir J       Date:  2019-01-24       Impact factor: 16.671

9.  Exercise and fluid challenge during right heart catheterisation for evaluation of dyspnoea.

Authors:  Ralf Ewert; Alexander Heine; Annegret Müller-Heinrich; Tom Bollmann; Anne Obst; Susanna Desole; Christine Knaak; Beate Stubbe; Christian F Opitz; Dirk Habedank
Journal:  Pulm Circ       Date:  2020-06-11       Impact factor: 3.017

10.  Echocardiographic Detection of Occult Diastolic Dysfunction in Pulmonary Hypertension After Fluid Challenge.

Authors:  Vineet Agrawal; Michele D'Alto; Robert Naeije; Emanuele Romeo; Meng Xu; Tufik R Assad; Ivan M Robbins; John H Newman; Meredith E Pugh; Anna R Hemnes; Evan L Brittain
Journal:  J Am Heart Assoc       Date:  2019-08-31       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.